Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population

被引：94

作者：

Jaggy, C

von Overbeck, J

Ledergerber, B

Schwarz, C

Egger, M

Rickenbach, M

Furrer, HJ

Telenti, A

Battegay, M

Flepp, M

Vernazza, P

Bernasconi, E

Hirschel, B ^{[1
]}

机构：

[1] Univ Hosp, Div Infect Dis, CH-1211 Geneva, Switzerland

[2] Swiss Re, Zurich, Switzerland

[3] Univ Zurich Hosp, CH-8091 Zurich, Switzerland

[4] Univ Hosp Bern, Div Infect Dis, Bern, Switzerland

[5] Univ Lausanne Hosp, Div Infect Dis, Lausanne, Switzerland

[6] Univ Basel Hosp, Div Infect Dis, CH-4031 Basel, Switzerland

[7] Cantonal Hosp St Gallen, St Gallen, Switzerland

[8] Cantonal Hosp Lugano, Lugano, Switzerland

[9] Dept Social & Prevent Med, Bern, Switzerland

来源：

LANCET | 2003年 / 362卷 / 9387期

关键词：

D O I：

10.1016/S0140-6736(03)14307-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Because of high death rates in the past, patients with HIV-1 cannot obtain life insurance. We measured mortality rates in the Swiss HIV Cohort Study (SHCS) from 1997 to 2001 and compared them with those of the Swiss reference population. In patients who were successfully treated with highly active anti-retroviral therapy (HAART), and who were not also infected with the hepatitis C virus, excess death rates were below five per thousand per year. Patients with successfully treated cancer have much the same excess death rates but are not excluded from life insurance policies.

引用

页码：877 / 878

页数：2

共 5 条

[1]

FRIISMOLLER N, 2003, 10 C RETR OPP INF BO

[2]

Kendall M.G., 1973, ADV THEORY STAT, V2

[3]

LEW EA, 1990, MED RISKS TRENDS MOR, V1

[4] Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study [J].

Mocroft, A ;

Brettle, R ;

Kirk, O ;

Blaxhult, A ;

Parkin, JM ;

Antunes, F ;

Francioli, P ;

Monforte, AD ;

Fox, Z ;

Lundgren, JD .

AIDS, 2002, 16 (12) :1663-1671

[5]

SUDRE P, 2000, SCHWEIZ MED WOCHENSC, V130, P1500

← 1 →